Close Menu
    What's Hot

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026
    Litigation

    Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

    July 22, 2026

    South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

    July 22, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Big Year of Growth for Life/Annuity Sidecar-Like Activity in 2025

      July 2, 2026

      Sixth Street To Become Majority Shareholder of Monument Re

      June 30, 2026

      Pacific Life Re Appoints Florence Durousseau as Head of Capital Solutions, Europe

      June 15, 2026

      Third Block Reinsurance Deal With Tokio Marine & Nichido Life for Pacific Life Re

      June 10, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Annuity Sales Notch Tenth Consecutive $100bn+ Quarter

      May 11, 2026

      End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

      July 22, 2026

      Q&A: Yona Chesner, Head of Pensions Investment, Cartwright Pension Trusts

      July 22, 2026

      UK Bulk Annuity Insurers’ Exposure to Private Credit Set To Remain Manageable

      July 20, 2026
      Milliman

      Competitive US Pension Risk Transfer Cost Decreased During June

      July 20, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026
      Litigation

      Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

      July 22, 2026

      South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

      July 22, 2026

      Optimism for Stronger Second Half in the Life Settlement Tertiary Market

      July 8, 2026

      US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

      July 8, 2026

      End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

      July 22, 2026
      Litigation

      Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

      July 22, 2026

      South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

      July 22, 2026

      Q&A: Yona Chesner, Head of Pensions Investment, Cartwright Pension Trusts

      July 22, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Shaping the Future of Health Insurance Through Innovation and Analytics

    Life Insurance June 10, 2026By Jessica Plewes and Lisa Balboa
    Share
    Twitter LinkedIn Email

    From ageing populations and rising chronic disease to the growth of personalised digital health solutions, Jessica Plewes and Lisa Balboa explore how analytics is tackling health insurance’s biggest challenges and what this means for the insurer of the future. 

    Global healthcare and private health insurance systems are arguably entering a period of significant strain and transformation. 

    Customer health needs are evolving, populations are ageing, chronic disease is rising faster than health systems can respond, and care is becoming more complex. This is placing public health systems under increasing strain in many countries. In response, customers are turning to private providers for faster access to care and ongoing support.  

    Health insurance in the digital age  

    Customers today are markedly different from traditional health insurance buyers. In this post-Covid-19 world, people are placing greater emphasis on staying healthy. They are more digital, more selective, and more focused on value. In short, they expect their cover to deliver benefits that clearly outweigh the cost. As a result, they are becoming more open to new products and propositions that address their increasingly complex care needs. 

    In response, insurers are leveraging digital channels across the full customer journey to attract and retain customers. This is impacting how customers purchase health insurance, how they engage with it and how they make claims. In particular, insurers are increasingly using digital channels across their well-being programmes and everyday customer interactions. AI is also being used to improve onboarding, reduce friction and tailor journeys from day one.  

    Digital health is also no longer limited to attracting and retaining highly active, healthy customers. Services such as virtual GP access, guided mental healthcare, physiotherapy, and smart-device nudges help insurers build ongoing relationships with customers across a wide range of health needs. Importantly, these tools also support preventive and early intervention strategies that create value for both customers and insurers. 

    These tools can improve customer health while reducing claim severity and frequency for insurers through proactive prevention and earlier intervention. These tools are also moving insurance beyond a one-size-fits-all model. The industry is shifting away from generic digital health services with low usage and limited relevance toward more personalised support tailored to customers’ specific health needs. Finding ways to use AI to connect customers with relevant digital and health services helps them see more value in their cover and makes them more likely to stay with their insurer over the long term. 

    Analytics for profitable growth 

    In recent times, insurers have done well in expanding participation, but retention is now the priority. The challenge will be for insurers to hold on to the right customers – those who represent good risk – and predictive analytics will be key to achieving that. 

    Digitalisation is generating far more data for insurers, while personalisation relies on advanced analytics behind the scenes to determine contextually appropriate actions for different customer groups. Machine learning and other sophisticated analytics now provide more granular insights, helping insurers to identify high-value segments that traditional one-way, two-way or linear analyses may miss. 

    At the same time, insurers must assess whether particular target customer groups align with their growth strategy and are likely to deliver sustainable profitability. The customer mix needs to fit with an insurer’s pricing assumptions, and both business mix and claims performance should be closely monitored to ensure it is tracking in line with expectations. 

    This makes it important for insurers to build early warning indicators within growth segments, for example by using pre-authorisation data to provide an early view of emerging claims trends. Robust dashboards and analytics strategies will be essential to spotting warning signs early and identifying profitable opportunities to expand market share. 

    Proposition development is also becoming increasingly customer- and segment-specific. Women’s health and metabolic health are examples of growing focus areas for targeted propositions. Products are also being shaped around distribution channels, such as digital platforms designed to appeal to younger, digitally-savvy demographics. 

    As propositions become more digitally integrated, customers are benefiting from improved access not only to insurers but also to services such as virtual GP appointments, mental health support, and online physiotherapy. Insurers are also leveraging strategic partnerships to offer these complementary health services. What sets these partnerships apart is how effectively insurers are able to use these services to meaningfully support health needs of customers in a relevant and timely manner. 

    Data-driven innovation improving access to new treatments 

    Emerging medical technologies and treatments across areas such as cancer, cardiovascular disease, and neurodegenerative diseases are highly promising. However, building enough value-based evidence across a sufficiently large population takes time. Insurers need this insight to identify which customer groups benefit most relative to cost and to ensure the right treatment reaches the right customer at the right time. 

    In product development, supplementary riders are creating access to new technologies and treatments while helping protect the core book from rising medical inflation. Instead of offering costly new treatments across the entire portfolio from the outset, insurers can ring-fence them as optional add-ons that customers choose to buy. 

    This approach allows insurers to build data on outcomes, value and the cost-effectiveness of new treatments while also making them available to customers who want access without impacting the sustainability of the traditional health insurance book. As medical science becomes more personalised, diagnostics and treatments are becoming more personalised as well. 

    The next opportunity lies in combining personalised diagnostics and treatments with more personalised propositions enabled by AI and digital transformation. Bringing these together could help insurers develop products that put cutting-edge treatments into the hands of the customers who need them most. 

    Meanwhile, pricing and claims monitoring can be strengthened through more sophisticated modelling techniques, such as GBMs, and through dynamic portfolio management approaches that support innovation. Insurers also need to equip pricing teams to deploy the machine learning models they build more independently, reducing reliance on IT when new rating factors emerge. 

    One of the most promising areas of innovation is where pricing and claims intersect, particularly in preventive care and early intervention. 

    The convergence imperative for health insurers 

    Partnerships between insurers, digital health providers, hospitals, care providers and technology platforms are likely to play a central role in the future of health insurance. What does that mean for a health insurer of the future? To succeed, they will need to deliver more joined-up care by bringing together the best of healthcare and technology. 

    That will require insurers to make better use of data. Importantly, this depends on building customer trust, managing the data securely and being transparent about how it is used. 

    Agentic AI is another emerging force. As it begins to help customers compare and buy policies based on evolving healthcare needs, insurers may need to adapt to new technology-driven distribution channels. 

    The industry will also remain focused on sustainability. Because premiums need to adequately support claims, affordability for customers is a critical part of that challenge. Insurers need to grow sustainably by attracting the right customers, controlling costs, improving health outcomes and lowering claims costs over time. 

    A key component of this is closer collaboration with providers. Historically, this has been difficult because payors and providers have worked to different priorities and performance measures. Even so, the time is right for stronger payor-provider partnerships. 

    In the Middle East, for example, we are seeing a shift towards value-based healthcare and more outcomes-driven payment models. Adoption is already underway in some countries, while in the US this approach is far more established. 

    Insurers that stay passive will face rising loss ratios, worsening affordability and declining relevance. In contrast, those that take an active role will help define the future of global healthcare. 

    Lisa Balboa is Senior Director, Insurance Consulting and Technology at WTW 

    Jessica Plewes is Senior Director, Insurance Consulting and Technology at WTW 

    2026 - June Commentary Mortality Risk Volume 2 Issue 6 – June 2026
    Share. Twitter LinkedIn Email

    Related Posts

    Royal Institute of British Architects 1974 Staff Pension Scheme Completes Bulk Purchase Annuity Buy-In With PIC

    June 29, 2026By LMI Newsdesk

    Energy Industry Pension Scheme Completes Bulk Purchase Annuity Buy-In With Canada Life

    June 24, 2026By LMI Newsdesk

    Passage of UK Pension Schemes Act Seen Boosting Size of DB Superfund Market

    June 24, 2026By Mark McCord

    UK Equity Release Market Waits on Fourth Quarter for Potentially Market-Altering Change

    June 24, 2026By Greg Winterton
    Latest Issue

    Optimism for Stronger Second Half in the Life Settlement Tertiary Market

    July 8, 2026

    Organ Transplant Improvements Test Life Expectancy Assessment Models

    July 8, 2026

    US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

    July 8, 2026

    Passage of UK Pension Schemes Act Seen Boosting Size of DB Superfund Market

    June 24, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.